Validation of the English version of the Parkinson Anxiety Scale in the Canadian population: Interim results
Objective: To validate the use of the English version of the PAS in Parkinson’s disease (PD) patients in Canada. Background: The PAS, originally developed to…Perturbation-based balance training in individuals with Parkinson’s disease and freezing of gait
Objective: In the current study, we assessed the effect of a multisession training program based on unpredictable AP and ML perturbations of body balance on…Impact of SARS-CoV-2 vaccine in Parkinson’s disease
Objective: To evaluate the impact of SARS-CoV-2 vaccine on motor and non-motor symptoms in Mexican people with Parkinson's disease (PwP). Background: Nowadays, as a consequence…Fundamental changes in Nerve Conduction Velocity and hyperpolarization latency of action potential of Sciatic nerve at the pre-motor phase in a chronic PD in vivo model: a neurotool for Parkinson’s disease diagnosis
Objective: To evaluate the changes in NCV and hyperpolarization latency of action potential of Sciatic nerve at the pre-motor phase in MPTP induced chronic PD…Analyzing the metabolic function of DJ-1 in the pathogenesis of Parkinson`s disease (PD) and Glioblastoma multiforme (GBM)
Objective: In this project, we are comprehensively studying the function of DJ-1 in PD and GBM to better understand its observed role in both, neurodegeneration…A Pilot Feasibility Study of Medium Chain Triglyceride Nutritional Ketosis and Parkinson’s Disease
Objective: To determine if nutritional ketosis supplemented by medium chain triglycerides (MCT) over the course of 2-3 weeks is acceptable and feasible in patients with…Face Name matching and memory complaints in Parkinson’s disease
Objective: We aim to portray memory impairment in patients with Parkinson’s disease (PD) from an objective and subjective angle by using an innovative cross-modal associative…A progress update on the Critical Path for Parkinson’s consortium’s pre-competitive 3DT initiative
Objective: To provide a progress update on the Critical Path for Parkinson’s (CPP) consortium’s “Digital Drug Development” (3DT) initiative, which was established in 2019 with…The acceptability of wearable devices to measure mobility in people with Parkinson’s Disease: observations from Mobilise-D
Objective: To explore the acceptability of wearable devices to remotely measure mobility in the Mobilise-D technical validation study (TVS). Background: When deploying tools to monitor…Classification of extremity movements by visual observation of signal transforms
Objective: To create a tool for raters certified in the MDS-UPDRS) [1] to blindly score online signal transforms of the output of the wearable sensors to…
- « Previous Page
- 1
- …
- 215
- 216
- 217
- 218
- 219
- …
- 338
- Next Page »